Market Exclusive

Analyst Activity – J P Morgan Chase & Co Reiterates Neutral on GlaxoSmithKline PLC (NYSE:GSK)

Analyst Ratings For GlaxoSmithKline PLC (NYSE:GSK)

Today, J P Morgan Chase & Co reiterated its Neutral rating on GlaxoSmithKline PLC (NYSE:GSK).

There are 1 sell rating, 7 hold ratings, 10 buy ratings on the stock.

The current consensus rating on GlaxoSmithKline PLC (NYSE:GSK) is Buy (Score: 2.50) with a consensus target price of $45.67 per share, a potential 7.05% upside.

Some recent analyst ratings include

Dividend information for GlaxoSmithKline PLC (NYSE:GSK)

GlaxoSmithKline PLC (NYSE:GSK) pays an annual dividend of Community Ranking: with a yield of 4.55% and an average dividend growth of -3.10% based on a 3 Year Average.

Dividend History for GlaxoSmithKline PLC (NYSE:GSK)

Recent Insider Trading Activity For GlaxoSmithKline PLC (NYSE:GSK)
GlaxoSmithKline PLC (NYSE:GSK) has insider ownership of 10.00% and institutional ownership of 8.98%.

Recent Trading Activity for GlaxoSmithKline PLC (NYSE:GSK)
Shares of GlaxoSmithKline PLC closed the previous trading session at 42.07 down -0.60 -1.42% with 2,280,071 shares trading hands.

Exit mobile version